AbCellera Biologics ABCL
NASDAQ ABCL
$13.92 +1.22 (+9.61%)
At close: Sep 28, 2026 · 4:00 PM EDT

AbCellera Biologics (ABCL) FCF Margin (2020 - 2026)

Updated

AbCellera Biologics (ABCL) recorded FCF Margin of 587.43% in Q2 2026, up 855.34 percentage points from -267.91% a year earlier and up 1036.67 percentage points from the prior quarter.

Analysis

AbCellera Biologics (ABCL) FCF Margin (2020 - 2026) Analysis & Trends

On a TTM basis, AbCellera Biologics' FCF Margin came in at -180.85% as of Jun 30, 2026, up 241.92 percentage points year-over-year; for FY2025, it came in at -231.69%, up 416.70 percentage points from FY2024.

  • Annual FCF Margin has a five-year change of -237.28 percentage points (FY2020 to FY2025).
  • Across earlier years, FCF Margin came in at -648.40% in FY2024 (-330.65 pp), -317.75% in FY2023 (-360.33 pp), 42.58% in FY2022 (-7.03 pp) and 49.61% in FY2021 (+44.03 pp).
  • The Q2 2026 figure is the highest quarterly FCF Margin in data going back to Q1 2020.
  • On a year-over-year basis, FCF Margin has increased for six consecutive quarters, with an average year-over-year change of +172.21 percentage points over the last eight quarters.
  • Peak year-over-year performance for FCF Margin in the last five years was a gain of 855.34 percentage points in Q2 2026, against a drop of 611.24 percentage points in Q2 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at -449.24% (Q1 2026), -99.40% (Q4 2025) and -687.01% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 28.82%
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 18.33%
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 26.96%
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 43.05%
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 34.72%
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 34.70%
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 44.00%
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 30.39%
10 AbCellera Biologics 3.89 Bn 3.89 Bn - 587.43%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 587.43%
Mar 31, 2026 -449.24%
Dec 31, 2025 -99.40%
Sep 30, 2025 -687.01%
Jun 30, 2025 -267.91%
Mar 31, 2025 -523.97%
Dec 31, 2024 -467.92%
Sep 30, 2024 -728.42%
Jun 30, 2024 -683.82%
Mar 31, 2024 -661.52%
Dec 31, 2023 -370.87%
Sep 30, 2023 -309.70%
Jun 30, 2023 -72.57%
Mar 31, 2023 -484.31%
Dec 31, 2022 86.25%
Sep 30, 2022 -137.40%
Jun 30, 2022 526.37%
Mar 31, 2022 27.08%
Dec 31, 2021 -18.76%
Sep 30, 2021 -263.36%
API Access

AbCellera Biologics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=ABCL&period=max&api_key=YOUR_API_KEY